The cytoblock preparation showed an invasive pancreatic ductal adenocarcinoma incompatible with a prostate cancer metastasis leading to the diagnosis of a PSMA positive pancreatic ductal adenocarcinoma. The gene discussed is FOLH1; the disease is prostate cancer.